[Federal Register Volume 87, Number 179 (Friday, September 16, 2022)]
[Notices]
[Page 56928]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20048]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-43-2022]


Foreign-Trade Zone (FTZ) 27--Boston, Massachusetts, Notification 
of Proposed Production Activity, Wyeth Pharmaceuticals, LLC (Shingles 
and Flu Vaccines), Andover, Massachusetts

    Wyeth Pharmaceuticals, LLC (Wyeth) submitted a notification of 
proposed production activity to the FTZ Board (the Board) for its 
facility in Andover, Massachusetts within Subzone 27R. The notification 
conforming to the requirements of the Board's regulations (15 CFR 
400.22) was received on September 8, 2022.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status material(s)/component(s) and 
specific finished product(s) described in the submitted notification 
(summarized below) and subsequently authorized by the Board. The 
benefits that may stem from conducting production activity under FTZ 
procedures are explained in the background section of the Board's 
website--accessible via www.trade.gov/ftz. The proposed finished 
product(s) and material(s)/component(s) would be added to the 
production authority that the Board previously approved for the 
operation, as reflected on the Board's website.
    The proposed finished products include mRNA Varicella-Zoster Virus 
Shingles Vaccine and saRNA Flu Vaccine (duty-free).
    The proposed foreign-status material/component is N1-Methyl-
Pseudouridine-5'-Triphosphate (duty rate, 6.5%). The request indicates 
that the material/component is subject to duties under Section 301 of 
the Trade Act of 1974 (section 301), depending on the country of 
origin. The applicable Section 301 decisions require subject 
merchandise to be admitted to FTZs in privileged foreign status (19 CFR 
146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is October 26, 
2022.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Diane Finver at 
[email protected].

    Dated: September 12, 2022.
Christopher Kemp,
Acting Executive Secretary.
[FR Doc. 2022-20048 Filed 9-15-22; 8:45 am]
BILLING CODE 3510-DS-P